Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Second Quarter 2013 Financial Results
8/15/2013 9:33:05 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BERKELEY HEIGHTS, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders today reported its financial results and business highlights for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.